Wednesday, October 06, 2021 1:21:55 PM
I am a long-term investor (2013 - 120,000+) that has followed this board for several years and enjoy reviewing the nuggets of gold that you all bring to the board.
I believe in the DCVAX science; however, like many of you, I have growing concerns about the companies leadership abilities to get this to TLD, regulators approval, and market.
I was shocked to see that Dave Innes apparently has time to troll the message board and is using material from it to respond to other investors. I would assume he could do better than that. I do understand they are in a "quiet period" but I think he could have done better or just keep quiet altogether and focus on getting us to TLD, approval, and market.
I was hoping for some form of public communication on the anniversary of the locking of data on October 5, 2020; instead, we get an AF article on October 6, 2021.
With Dave following the board, I would like to get his and the other IHUB NWBO board member's thoughts.
Dave - When will we receive a voting proxy to increase the share count to cover the suspended warrants that exceed the current share count?
Dave - How many shares will LP and LG receive for a "job well done" in further diluting shareholders?
I certainly hope the journal we all seem to be awaiting is a highly credible journal vs the lower tier JTM journal.
Fellow Board Members what are your thoughts on voting for additional shares to cover the warrants that LP and LG provided to themselves and others?
Also, what are your thoughts on giving them additional shares on top of their current shares as a reward for all the good work they have done the past couple of years?
Fortunately, I have sold some of my original 160,000 shares to get my cost basis to $0; thus, de-risking this investment because of the concerns with the company leadership.
DCVAX Dreaming!
Best wishes all!
Recent NWBO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:10:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 09:24:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM